An open-label pilot study of aripiprazole for male and female Veterans with chronic post-traumatic stress disorder who respond suboptimally to antidepressants

No abstract is available for this paper.

• Publication year

  2012

• Venue

  International Clinical Psychopharmacology

• Publication date

  2012-07-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1097/YIC.0b013e328352ef4ePMID 22475888
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• An open-label assessment of aripiprazole in the treatment of PTSD.

  2025influential reference
• Predictive value of early improvement in bipolar depression trials: a post-hoc pooled analysis of two 8-week aripiprazole studies.

  2025influential reference
• Prospective study to evaluate the efficacy of aripiprazole as a monotherapy in patients with severe chronic posttraumatic stress disorder: an open trial.

  2025influential reference
• Diagnostic and Statistical Manual of Mental Disorders

  2013cited by this paper
• Adjunctive risperidone treatment for antidepressant-resistant symptoms of chronic military service-related PTSD: a randomized trial.

  2011cited by this paper
• Metabolic side effects of antipsychotic drug treatment--pharmacological mechanisms.

  2010cited by this paper
• Prevalence of mental health problems and functional impairment among active component and National Guard soldiers 3 and 12 months following combat in Iraq.

  2010cited by this paper
• Pharmacologic alternatives to antidepressants in posttraumatic stress disorder: a systematic review.

  2009influential reference
• Mental Disorders, Comorbidity and Suicidal Behavior: Results from the National Comorbidity Survey Replication

  2009cited by this paper
• Association of trauma exposure with psychiatric morbidity in military veterans who have served since September 11, 2001.

  2009cited by this paper
• Guideline Watch (March 2009): Practice Guideline for the Treatment of Patients with Acute Stress Disorder and Posttraumatic Stress Disorder

  2009cited by this paper
• Metabolic Screening After the American Diabetes Association's Consensus Statement on Antipsychotic Drugs and Diabetes

  2009cited by this paper
• The utility of the Beck Depression Inventory Fast Screen (BDI‐FS) in a pain clinic population

  2009influential reference
• A 24-week, multicenter, open-label, randomized study to compare changes in glucose metabolism in patients with schizophrenia receiving treatment with olanzapine, quetiapine, or risperidone.

  2009cited by this paper
• The incidence of diabetes in atypical antipsychotic users differs according to agent—results from a multisite epidemiologic study

  2009cited by this paper
• Posttraumatic stress disorder and suicide attempts in a community sample of urban american young adults.

  2009cited by this paper
• Change in metabolic syndrome parameters with antipsychotic treatment in the CATIE Schizophrenia Trial: prospective data from phase 1.

  2008cited by this paper
• Aripiprazole in the treatment of posttraumatic stress disorder: an open-label trial.

  2008influential reference
• Addressing cardiometabolic risk during treatment with antipsychotic medications

  2008influential reference
• The atypical antipsychotics olanzapine and risperidone in the treatment of posttraumatic stress disorder: a meta-analysis of randomized, double-blind, placebo-controlled clinical trials

  2008influential reference
• Adjunctive Aripiprazole in Combat-Related Posttraumatic Stress Disorder

  2007cited by this paper
• Aripiprazole in a Therapy-resistant Patient with Borderline Personality and Post-Traumatic Stress Disorder

  2007cited by this paper
• Metabolic considerations in the use of antipsychotic medications: a review of recent evidence.

  2007cited by this paper
• Switching antipsychotics as a treatment strategy for antipsychotic-induced weight gain and dyslipidemia.

  2007cited by this paper
• Quetiapine as an adjunctive treatment for post-traumatic stress disorder: an 8-week open-label study

  2006influential reference
• Risperidone monotherapy for post-traumatic stress disorder related to sexual assault and domestic abuse in women

  2006influential reference
• Aripiprazole in the management of post-traumatic stress disorder symptoms in returning Global War on Terrorism veterans.

  2006cited by this paper
• Aripiprazole as an augmentor of selective serotonin reuptake inhibitors in depression and anxiety disorder patients

  2005cited by this paper
• Adjunctive risperidone in the treatment of chronic combat-related posttraumatic stress disorder.

  2005influential reference
• Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication.

  2005cited by this paper
• Practice guideline for the treatment of patients with acute stress disorder and posttraumatic stress disorder.

  2004cited by this paper
• Treatment-Resistant Posttraumatic Stress Disorder: Strategies for Intervention

  2004cited by this paper
• Remission in post-traumatic stress disorder (PTSD): effects of sertraline as assessed by the Davidson Trauma Scale, Clinical Global Impressions and the Clinician-Administered PTSD scale

  2004cited by this paper
• Can physiologic assessment and side effects tease out differences in PTSD trials? A double-blind comparison of citalopram, sertraline, and placebo.

  2003cited by this paper
• Treatment of antidepressant-associated sexual dysfunction with sildenafil: a randomized controlled trial.

  2003cited by this paper
• Treatment of antidepressant-associated sexual dysfunction with sildenafil: a randomized controlled trial.

  2003cited by this paper
• Quetiapine Treatment in Patients with Posttraumatic Stress Disorder: An Open Trial of Adjunctive Therapy

  2003influential reference
• Mirtazapine vs. placebo in posttraumatic stress disorder: a pilot trial.

  2003cited by this paper
• Davidson Trauma Scale (DTS): Normative scores in the general population and effect sizes in placebo‐controlled SSRI trials

  2002influential reference
• Medical service utilization by veterans seeking help for posttraumatic stress disorder.

  2002cited by this paper
• Fluoxetine versus placebo in posttraumatic stress disorder.

  2002cited by this paper
• Olanzapine treatment for post-traumatic stress disorder: an open-label study

  2001influential reference
• Efficacy and safety of paroxetine treatment for chronic PTSD: a fixed-dose, placebo-controlled study.

  2001cited by this paper
• Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability.

  2000cited by this paper
• Lack of Efficacy for Fluoxetine in PTSD: A Placebo Controlled Trial in Combat Veterans

  2000cited by this paper
• Functional Impairment and Utilization of Services Associated With Posttraumatic Stress in the Community

  1999cited by this paper
• Psychotic symptoms in combat-related posttraumatic stress disorder.

  1999cited by this paper
• A pilot study of mirtazapine in post-traumatic stress disorder.

  1999influential reference
• Assessment of a new self-rating scale for post-traumatic stress disorder

  1997cited by this paper
• Posttraumatic stress disorder in the National Comorbidity Survey.

  1995cited by this paper
• The development of a Clinician-Administered PTSD Scale

  1995influential reference
• Post-traumatic stress disorder in the community: an epidemiological study

  1991influential reference
• Relationship between hopelessness and ultimate suicide: a replication with psychiatric outpatients.

  1990cited by this paper
• A Rating Scale for Drug-Induced Akathisia

  1989cited by this paper
• The positive and negative syndrome scale (PANSS) for schizophrenia.

  1987influential reference

• Pharmacological strategies for post-traumatic stress disorder (PTSD): From animal to clinical studies.

  2022cites this paper
• Adjunctive treatment with brexpiprazole and escitalopram reduces behavioral stress responses and increase hypothalamic NPY immunoreactivity in a rat model of PTSD-like symptoms.

  2018cites this paper
• Medication for Sleep Problems in Posttraumatic Stress Disorder

  2018cites this paper
• Aripiprazole for Post-traumatic Stress Disorder: A Systematic Review

  2017cites this paper
• Pharmacogenetics and Pharmacotherapy of Military Personnel Suffering from Post-traumatic Stress Disorder

  2017cites this paper
• The role of Ect in Posttraumatic Stress Disorder: A Systematic Review

  2017cites this paper
• Ramelteon Improves Post-traumatic Stress Disorder-Like Behaviors Exhibited by Fatty Acid-Binding Protein 3 Null Mice

  2017cites this paper
• Treatment-refractory posttraumatic stress disorder (TRPTSD): a review and framework for the future.

  2016cites this paper
• Real-Time fMRI Neurofeedback with War Veterans with Chronic PTSD: A Feasibility Study

  2016cites this paper
• A pilot randomized placebo-controlled trial of adjunctive aripiprazole for chronic PTSD in US military Veterans resistant to antidepressant treatment

  2015influential citation
• Non-Antidepressant Long-term Treatment in Post-Traumatic Stress Disorder (PTSD).

  2015cites this paper
• A review of atypical antipsychotics and their utility in post-traumatic stress disorder

  2013cites this paper
• Atypical Antipsychotics in the Treatment of Posttraumatic Stress Disorder

  2013cites this paper